Clinical trial
The Effect of Donepezil on Glycemic Control in Type II Diabetics
NCT04507438 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Donepezil on Glycemic Control in Type II Diabetics
- Lead sponsor
- University of Maryland, Baltimore
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- July 12, 2019
- Completion date
- September 12, 2023
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.